⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NKTX News
Nkarta, Inc. Common Stock
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
globenewswire.com
NKTX
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
globenewswire.com
NKTX
A Clinical-Stage Cancer Company Is Putting AI to Work Designing Its Next Generation of Tumor-Targeting Drugs
prnewswire.com
CMPX
NKTX
GTBP
RXRX
FATE
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
globenewswire.com
NKTX
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
globenewswire.com
GTBP
FATE
NKTX
CMPX
CRBU
Form 8-K
sec.gov
NKTX
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
globenewswire.com
IOVA
GTBP
NKTX
IBRX
FATE
The $13 Million Company Teaching the Immune System to Hunt Cancer
prnewswire.com
NKTX
GTBP
IBRX
FATE
ARTV
Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
SNGX
IPHA
BMY
NKTX
AZN
MRK
TAK
NVS
GMAB
ABBV
BIIB
CRSP
INCY
ALKS
PFE
REGN
GILD
AMGN
Three TriKE Candidates In Clinic As NK Cell Engager Field Reorganizes
prnewswire.com
NKTX
GTBP
IBRX
FATE
INMB